About: MTEP

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

3-((2-Methyl-4-thiazolyl)ethynyl)pyridine (MTEP) is a research drug that was developed by Merck & Co. as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5. Identified through structure-activity relationship studies on an older mGluR5 antagonist MPEP, MTEP has subsequently itself acted as a lead compound for newer and even more improved drugs.

Property Value
dbo:abstract
  • 3-((2-Methyl-4-thiazolyl)ethynyl)pyridine (MTEP) is a research drug that was developed by Merck & Co. as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5. Identified through structure-activity relationship studies on an older mGluR5 antagonist MPEP, MTEP has subsequently itself acted as a lead compound for newer and even more improved drugs. MTEP is both more potent and more selective than MPEP as a mGluR5 antagonist, and produces similar neuroprotective, antidepressant, analgesic, and anxiolytic effects but with either similar or higher efficacy depending on the test used. MTEP also has similar efficacy to MPEP in reducing the symptoms of morphine withdrawal, and has anti-addictive effects in a variety of animal models, both reducing ethanol self-administration, and also decreasing the addictive effects of nicotine, cocaine and methamphetamine. (en)
dbo:casNumber
  • 329205-68-7
dbo:pubchem
  • 9794218
dbo:thumbnail
dbo:wikiPageID
  • 20245287 (xsd:integer)
dbo:wikiPageLength
  • 16342 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1122882327 (xsd:integer)
dbo:wikiPageWikiLink
dbp:alt
  • Skeletal formula (en)
  • Space-filling model (en)
dbp:c
  • 11 (xsd:integer)
dbp:casNumber
  • 329205 (xsd:integer)
dbp:chemspiderid
  • 7969985 (xsd:integer)
dbp:h
  • 8 (xsd:integer)
dbp:image
  • MTEP-3D-spacefill.png (en)
dbp:iupacName
  • 3 (xsd:integer)
dbp:iupharLigand
  • 3336 (xsd:integer)
dbp:n
  • 2 (xsd:integer)
dbp:pubchem
  • 9794218 (xsd:integer)
dbp:s
  • 1 (xsd:integer)
dbp:smiles
  • CC1=NCC#CC2=CN=CC=C2 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • NRBNGHCYDWUVLC-UHFFFAOYSA-N (en)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 424696647 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:width
  • 200 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • 3-((2-Methyl-4-thiazolyl)ethynyl)pyridine (MTEP) is a research drug that was developed by Merck & Co. as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5. Identified through structure-activity relationship studies on an older mGluR5 antagonist MPEP, MTEP has subsequently itself acted as a lead compound for newer and even more improved drugs. (en)
rdfs:label
  • MTEP (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License